Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Biological, Genetic, and Lifestyle Risk Factors for Developing Colorectal Adenomas or Polyps in Participants Undergoing Colonoscopy

Lead Sponsor:

Vanderbilt University

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Colorectal Cancer

Precancerous Condition

Eligibility:

All Genders

40-75 years

Brief Summary

RATIONALE: Collecting and storing samples of tissue, blood, and other body fluids to test in the laboratory and gathering information about health and lifestyle from participants may help doctors lear...

Detailed Description

OBJECTIVES: * To recruit 7,000 participants who are planning to undergo colonoscopy. * To collect questionnaires and medical records from these participants. * To collect biological samples, includin...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Scheduled to undergo colonoscopy at the Vanderbilt University Medical Center or the Tennessee Valley Veterans Administration Medical Center
  • No prior genetic colorectal cancer syndromes or colorectal adenoma
  • PATIENT CHARACTERISTICS:
  • Must have a permanent residence and a telephone number
  • Able to speak and understand English
  • No prior inflammatory bowel disease
  • No prior cancer other than nonmelanoma skin cancer
  • Not a current resident in a correctional facility
  • No other rare exclusion that would prevent the collection of study data (e.g., extensive memory loss for past exposures), impair ability to provide informed consent, or make the participant an atypical colonoscopy patient (e.g., colonoscopy for organ transplant evaluation)
  • No prior extensive knowledge or contact with the investigation/protocol/hypotheses (the study collaborator or reviewer)
  • PRIOR CONCURRENT THERAPY:
  • No prior partial or complete colon resection
  • No concurrent participation in a clinical trial involving the prevention of colon polyps

Exclusion

    Key Trial Info

    Start Date :

    January 1 2003

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    November 30 2025

    Estimated Enrollment :

    8108 Patients enrolled

    Trial Details

    Trial ID

    NCT00625066

    Start Date

    January 1 2003

    End Date

    November 30 2025

    Last Update

    December 17 2025

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Vanderbilt-Ingram Cancer Center - Cool Springs

    Nashville, Tennessee, United States, 37064

    2

    Vanderbilt-Ingram Cancer Center at Franklin

    Nashville, Tennessee, United States, 37064

    3

    Veterans Affairs Medical Center - Nashville

    Nashville, Tennessee, United States, 37212

    4

    Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, United States, 37232-6838